InterventionsReview
Sodium-Glucose Cotransporter 2 Inhibitors in Valvular Heart Disease: Cardiovascular Benefit, Valve-Specific Effects, and Evidence Gaps-A Structured Narrative Review
Journal of Clinical Medicine
- SGLT2 inhibitors
- Valvular heart disease
- Aortic valve insufficiency
- Aortic valve stenosis
- Heart failure
- Humans
The paper
Rada M, Craciun ML, Pah AM et al.
Journal of Clinical Medicine · 17 Aug 2026
